You just read:

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

News provided by

Abbott

21 Mar, 2013, 00:07 GMT